Terms: = Brain cancer AND FOXO3, FKHRL1, 2309, ENSG00000118689, MGC31925, MGC12739, FOXO2, FOXO3A, O43524, AF6q21, FKHRL1P2, DKFZp781A0677 AND Treatment
18 results:
1. GNA13 inhibits glioblastoma metastasis via the ERKs/foxo3 signaling pathway.
Yi Q; Huang M; Zhang X; Xu Z; Sun J; Wang S; Xu H; Du Z; Liu M
Cell Signal; 2023 Sep; 109():110789. PubMed ID: 37392861
[TBL] [Abstract] [Full Text] [Related]
2. TNFSF13 Is a Novel Onco-Inflammatory Marker and Correlates With Immune Infiltration in Gliomas.
Chen R; Wang X; Dai Z; Wang Z; Wu W; Hu Z; Zhang X; Liu Z; Zhang H; Cheng Q
Front Immunol; 2021; 12():713757. PubMed ID: 34712225
[TBL] [Abstract] [Full Text] [Related]
3. EGFR/foxo3a/BIM signaling pathway determines chemosensitivity of BMP4-differentiated glioma stem cells to temozolomide.
Ciechomska IA; Gielniewski B; Wojtas B; Kaminska B; Mieczkowski J
Exp Mol Med; 2020 Aug; 52(8):1326-1340. PubMed ID: 32788653
[TBL] [Abstract] [Full Text] [Related]
4. Diffuse Intrinsic Pontine Glioma (DIPG): Breakthrough and Clinical Perspective.
Perrone MG; Ruggiero A; Centonze A; Carrieri A; Ferorelli S; Scilimati A
Curr Med Chem; 2021; 28(17):3287-3317. PubMed ID: 32767913
[TBL] [Abstract] [Full Text] [Related]
5. Transcriptional activation of SIRT6 via fkhrl1/foxo3a inhibits the Warburg effect in glioblastoma cells.
Dong Z; Zhong X; Lei Q; Chen F; Cui H
Cell Signal; 2019 Aug; 60():100-113. PubMed ID: 31004738
[TBL] [Abstract] [Full Text] [Related]
6. The tumor suppressor foxo3a mediates the response to EGFR inhibition in glioblastoma cells.
Ramis G; Villalonga-Planells R; Serra-Sitjar M; Brell M; Fernández de Mattos S; Villalonga P
Cell Oncol (Dordr); 2019 Aug; 42(4):521-536. PubMed ID: 30980364
[TBL] [Abstract] [Full Text] [Related]
7. Integrated proximal proteomics reveals IRS2 as a determinant of cell survival in ALK-driven neuroblastoma.
Emdal KB; Pedersen AK; Bekker-Jensen DB; Lundby A; Claeys S; De Preter K; Speleman F; Francavilla C; Olsen JV
Sci Signal; 2018 Nov; 11(557):. PubMed ID: 30459283
[TBL] [Abstract] [Full Text] [Related]
8. Identification and characterization of two functional variants in the human longevity gene foxo3.
Flachsbart F; Dose J; Gentschew L; Geismann C; Caliebe A; Knecht C; Nygaard M; Badarinarayan N; ElSharawy A; May S; Luzius A; Torres GG; Jentzsch M; Forster M; Häsler R; Pallauf K; Lieb W; Derbois C; Galan P; Drichel D; Arlt A; Till A; Krause-Kyora B; Rimbach G; Blanché H; Deleuze JF; Christiansen L; Christensen K; Nothnagel M; Rosenstiel P; Schreiber S; Franke A; Sebens S; Nebel A
Nat Commun; 2017 Dec; 8(1):2063. PubMed ID: 29234056
[TBL] [Abstract] [Full Text] [Related]
9. Three-dimensional tumor cell growth stimulates autophagic flux and recapitulates chemotherapy resistance.
Bingel C; Koeneke E; Ridinger J; Bittmann A; Sill M; Peterziel H; Wrobel JK; Rettig I; Milde T; Fernekorn U; Weise F; Schober A; Witt O; Oehme I
Cell Death Dis; 2017 Aug; 8(8):e3013. PubMed ID: 28837150
[TBL] [Abstract] [Full Text] [Related]
10. TRIB2 confers resistance to anti-cancer therapy by activating the serine/threonine protein kinase AKT.
Hill R; Madureira PA; Ferreira B; Baptista I; Machado S; Colaço L; Dos Santos M; Liu N; Dopazo A; Ugurel S; Adrienn A; Kiss-Toth E; Isbilen M; Gure AO; Link W
Nat Commun; 2017 Mar; 8():14687. PubMed ID: 28276427
[TBL] [Abstract] [Full Text] [Related]
11. foxo3a induces temozolomide resistance in glioblastoma cells via the regulation of β-catenin nuclear accumulation.
Xu K; Zhang Z; Pei H; Wang H; Li L; Xia Q
Oncol Rep; 2017 Apr; 37(4):2391-2397. PubMed ID: 28260024
[TBL] [Abstract] [Full Text] [Related]
12. FoxO proteins or loss of functional p53 maintain stemness of glioblastoma stem cells and survival after ionizing radiation plus PI3K/mTOR inhibition.
Firat E; Niedermann G
Oncotarget; 2016 Aug; 7(34):54883-54896. PubMed ID: 27448972
[TBL] [Abstract] [Full Text] [Related]
13. Methylseleninic acid promotes antitumour effects via nuclear foxo3a translocation through Akt inhibition.
Tarrado-Castellarnau M; Cortés R; Zanuy M; Tarragó-Celada J; Polat IH; Hill R; Fan TW; Link W; Cascante M
Pharmacol Res; 2015 Dec; 102():218-34. PubMed ID: 26375988
[TBL] [Abstract] [Full Text] [Related]
14. BRCA1-IRIS inactivation sensitizes ovarian tumors to cisplatin.
Paul BT; Blanchard Z; Ridgway M; ElShamy WM
Oncogene; 2015 Jun; 34(23):3036-52. PubMed ID: 25132263
[TBL] [Abstract] [Full Text] [Related]
15. Systemic approaches identify a garlic-derived chemical, Z-ajoene, as a glioblastoma multiforme cancer stem cell-specific targeting agent.
Jung Y; Park H; Zhao HY; Jeon R; Ryu JH; Kim WY
Mol Cells; 2014 Jul; 37(7):547-53. PubMed ID: 25078449
[TBL] [Abstract] [Full Text] [Related]
16. foxo3a functions as a key integrator of cellular signals that control glioblastoma stem-like cell differentiation and tumorigenicity.
Sunayama J; Sato A; Matsuda K; Tachibana K; Watanabe E; Seino S; Suzuki K; Narita Y; Shibui S; Sakurada K; Kayama T; Tomiyama A; Kitanaka C
Stem Cells; 2011 Sep; 29(9):1327-37. PubMed ID: 21793107
[TBL] [Abstract] [Full Text] [Related]
17. [Transsphenoidal surgery for prolactinomas: results and prognosis].
Sinkūnas K; Rastenyte D; Deltuva VP; Knispelis R; Tamasauskas A
Medicina (Kaunas); 2007; 43(9):691-7. PubMed ID: 17986841
[TBL] [Abstract] [Full Text] [Related]
18. Trastuzumab-resistant HER2-driven breast cancer cells are sensitive to epigallocatechin-3 gallate.
Eddy SF; Kane SE; Sonenshein GE
Cancer Res; 2007 Oct; 67(19):9018-23. PubMed ID: 17909003
[TBL] [Abstract] [Full Text] [Related]
